Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

The tech giant's Damo Academy secured a "breakthrough device" designation from the US regulator for its pancreatic cancer-detecting AI model, Damo Panda Alibaba Group Holding's research arm, Damo ...

Burjeel Holdings has entered a partnership with US-based Paige for deploying AI approved by the Food and Drug Administration ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

Use of certain cancer drugs declines significantly after the emergence of negative confirmatory trial data, even though the medications remain available through off-label use.

The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Tempest Therapeutics is eyeing a strategic partner to continue amezalpat’s development amid ‘unavailable capital markets'.

Breast cancer is the leading cause of cancer death among Latinas. Testing for breast density and other risk factors can save ...